Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Momoe Kassai"'
Publikováno v:
Microorganisms, Vol 12, Iss 1, p 106 (2024)
Intestinal microbiota and Toll-like receptor 2 (TLR2), which can bind lipoteichoic acid produced by microbiota, might contribute to the pathogenesis of Parkinson’s disease (PD), which is characterized by α-synuclein accumulation. Although the cont
Externí odkaz:
https://doaj.org/article/f0b8d99a5f99414b83c7ee6138411af2
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 44:128115
Kynurenine monooxygenase (KMO) is expected to be a good drug target to treat Huntington's disease (HD). This study presents the structure-activity relationship of pyridazine derivatives to find novel KMO inhibitors. The most promising compound 14 res
Autor:
Mari Miyajima, Mika Endo, Yoko Deai, Momoe Kassai, Hitoshi Suda, Masahiro Yahata, Yoshiaki Isobe, Hidenori Kimura
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 33:127753
Huntington's disease (HD) is one of the serious neurodegenerative diseases and no disease modifiers are available to date. The correction of unbalanced kynurenine pathway metabolites may be useful to treat disease progression and kynurenine monooxyge
Autor:
Momoe Kassai, Makoto Takata, Wataru Hirose, Kohzo Yoshida, Satoki Imai, Takayoshi Yamamoto, Shun Hayashi, Yukiyo Arai, Yoshihiro Kato
Publikováno v:
Bioorganicmedicinal chemistry letters. 26(16)
The design, synthesis and SAR studies of novel 4,5,6,7-tetrahydropyrazolopyrazines as metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulators (NAMs) are presented in this letter. Starting from a HTS hit compound (1, IC50=477nM), opt